• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Plasmablastic myeloma transformation of light-chain multiple myeloma

by | Apr 30, 2024 | Publications

J Clin Exp Hematop. 2024 Apr 30. doi: 10.3960/jslrt.24004. Online ahead of print. ABSTRACT Plasmablastic myeloma (PBM) is an uncommon and aggressive morphologic variant of multiple myeloma (MM). The neoplastic immature cells exhibit diverse morphology, posing a...

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

by | Apr 30, 2024 | Publications

Blood Cancer J. 2024 Apr 29;14(1):74. doi: 10.1038/s41408-024-01053-3. ABSTRACT Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM). The risk of progression of SMM patients is not uniform, thus different progression-risk models have been developed,...

Implementing multi-level network meta-regression for time-to-event outcomes: A case study in relapsed refractory multiple myeloma

by | Apr 29, 2024 | Publications

Value Health. 2024 Apr 26:S1098-3015(24)02349-0. doi: 10.1016/j.jval.2024.04.017. Online ahead of print. ABSTRACT OBJECTIVES: Multi-level network meta-regression (ML-NMR) leverages individual patient data (IPD) and aggregate data (AD) from a network of randomized...

Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment

by | Apr 29, 2024 | Publications

Ibrain. 2023 Sep 6;9(4):421-430. doi: 10.1002/ibra.12132. eCollection 2023 Winter. ABSTRACT The incidence of multiple myeloma (MM) is increasing year by year, requiring chemotherapy drugs to control the condition. With the advent of new proteasome inhibitors,...

Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study

by | Apr 29, 2024 | Publications

Int J Hematol Oncol Stem Cell Res. 2024 Jan 1;18(1):64-74. doi: 10.18502/ijhoscr.v18i1.14745. ABSTRACT Background: To assess the efficacy of autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with acute renal failure....

Seven-year Follow-up of India’s First Sequential Hematopoietic Stem Cell and Kidney Transplant for Multiple Myeloma

by | Apr 29, 2024 | Publications

Indian J Nephrol. 2024 Mar-Apr;34(2):205. doi: 10.4103/ijn.ijn_234_23. Epub 2023 Sep 29. NO ABSTRACT PMID:38681022 | PMC:PMC11044661 | DOI:10.4103/ijn.ijn_234_23
« Older Entries
Next Entries »

Recent Content

  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • (no title)
  • Peroxiredoxins as novel indicators in multiple myeloma associated with ferroptosis and immune infiltration
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT